Loading...
•
Dec 31, 2025
Hinge Health, Inc. Q4 2025 Earnings Report
Hinge Health delivered record fourth-quarter results with strong revenue growth, expanding margins, and increased profitability.
Key Takeaways
Hinge Health reported strong Q4 2025 performance with 46% revenue growth year over year, higher gross margins, solid operating income growth, and robust free cash flow generation.
Revenue grew 46% year over year to 170726000 dollars.
GAAP operating income increased to 27256000 dollars with margin expansion.
Non-GAAP diluted EPS reached 0.49 dollars.
Free cash flow increased 65% year over year to 61532000 dollars.
Forward Guidance
For Q1 2026, the company expects continued strong revenue growth and expanding non-GAAP operating income.
Positive Outlook
- Q1 2026 revenue expected between 171000000 and 173000000 dollars.
- Full year 2026 revenue expected between 732000000 and 742000000 dollars.
- Q1 2026 non-GAAP income from operations expected between 30000000 and 32000000 dollars.
- Full year 2026 non-GAAP operating margin expected at approximately 21% at midpoint.
- Strong cash position of 478800000 dollars including marketable securities and restricted cash.
Challenges Ahead
- GAAP operating results may fluctuate due to stock-based compensation expenses.
- Income tax effects may create variability in GAAP profitability.
- Acquisition-related expenses may impact comparability.
- Restructuring and other non-recurring charges could affect results.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...